Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
3.
PLoS Biol ; 9(6): e1001090, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21713032

RESUMEN

Patients affected by chronic inflammatory disorders display high amounts of soluble CD95L. This homotrimeric ligand arises from the cleavage by metalloproteases of its membrane-bound counterpart, a strong apoptotic inducer. In contrast, the naturally processed CD95L is viewed as an apoptotic antagonist competing with its membrane counterpart for binding to CD95. Recent reports pinpointed that activation of CD95 may attract myeloid and tumoral cells, which display resistance to the CD95-mediated apoptotic signal. However, all these studies were performed using chimeric CD95Ls (oligomerized forms), which behave as the membrane-bound ligand and not as the naturally processed CD95L. Herein, we examine the biological effects of the metalloprotease-cleaved CD95L on CD95-sensitive activated T-lymphocytes. We demonstrate that cleaved CD95L (cl-CD95L), found increased in sera of systemic lupus erythematosus (SLE) patients as compared to that of healthy individuals, promotes the formation of migrating pseudopods at the leading edge of which the death receptor CD95 is capped (confocal microscopy). Using different migration assays (wound healing/Boyden Chamber/endothelial transmigration), we uncover that cl-CD95L promotes cell migration through a c-yes/Ca²âº/PI3K-driven signaling pathway, which relies on the formation of a CD95-containing complex designated the MISC for Motility-Inducing Signaling Complex. These findings revisit the role of the metalloprotease-cleaved CD95L and emphasize that the increase in cl-CD95L observed in patients affected by chronic inflammatory disorders may fuel the local or systemic tissue damage by promoting tissue-filtration of immune cells.


Asunto(s)
Movimiento Celular/inmunología , Proteína Ligando Fas/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Apoptosis/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células HEK293 , Humanos , Lupus Eritematoso Sistémico/sangre , Seudópodos/fisiología , Transducción de Señal , Migración Transendotelial y Transepitelial/fisiología , Receptor fas/inmunología , Receptor fas/metabolismo , Familia-src Quinasas/fisiología
4.
Proc Natl Acad Sci U S A ; 108(47): 19072-7, 2011 11 22.
Artículo en Inglés | MEDLINE | ID: mdl-22065776

RESUMEN

The death receptor CD95 plays a pivotal role in immune surveillance and immune tolerance. Binding of CD95L to CD95 leads to recruitment of the adaptor protein Fas-associated death domain protein (FADD), which in turn aggregates caspase-8 and caspase-10. Efficient formation of the CD95/FADD/caspase complex, known as the death-inducing signaling complex (DISC), culminates in the induction of apoptosis. We show that cells exposed to CD95L undergo a reorganization of the plasma membrane in which the Ca(2+) release-activated Ca(2+) channel Orai1 and the endoplasmic reticulum-resident activator stromal interaction molecule 1 colocalize with CD95 into a micrometer-sized cluster in which the channel elicits a polarized entry of calcium. Orai1 knockdown and expression of a dominant negative construct (Orai1E106A) reveal that on CD95 engagement, the Orai1-driven localized Ca(2+) influx is fundamental to recruiting the Ca(2+)-dependent protein kinase C (PKC) ß2 to the DISC. PKCß2 in turn transiently holds the complex in an inactive status, preventing caspase activation and transmission of the apoptotic signal. This study identifies a biological role of Ca(2+) and the Orai1 channel that drives a transient negative feedback loop, introducing a lag phase in the early steps of the CD95 signal. We suggest that these localized events provide a time of decision to prevent accidental cell death.


Asunto(s)
Apoptosis/fisiología , Canales de Calcio/metabolismo , Calcio/metabolismo , Complejos Multiproteicos/metabolismo , Proteína Quinasa C/metabolismo , Receptor fas/metabolismo , Western Blotting , Caspasa 10/metabolismo , Caspasa 8/metabolismo , Línea Celular , Proteína Ligando Fas/metabolismo , Proteína de Dominio de Muerte Asociada a Fas/metabolismo , Citometría de Flujo , Humanos , Inmunoprecipitación , Microscopía Confocal , Proteína ORAI1 , Proteína Quinasa C beta , Estadísticas no Paramétricas
5.
Anticancer Drugs ; 22(6): 481-7, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21317766

RESUMEN

Death receptors play a crucial role in immune surveillance and cellular homeostasis, two processes circumvented by tumor cells. CD95 (also termed Fas or APO1) is a transmembrane receptor, which belongs to the tumor necrosis factor receptor superfamily, and induces a potent apoptotic signal. Initial steps of the CD95 signal take place through protein/protein interactions that bring zymogens such as caspase-8 and caspase-10 closer. Aggregation of these procaspases leads to their autoprocessing, to the release of activated caspases in the cytosol, which causes a caspase cascade, and to the transmission of the apoptotic signal. In parallel, CD95 engagement drives an increase in the intracellular calcium concentration (Ca(2+))i whose origin and functions remain controversial. Although Ca(2+) ions play a central role in apoptosis/necrosis induction, recent studies have highlighted a protective role of Ca(2+) in death receptor signaling. In the light of these findings, we discuss the role of Ca(2+) ions as modulators of CD95 signaling.


Asunto(s)
Calcio/fisiología , Transducción de Señal/fisiología , Receptor fas/fisiología , Apoptosis/efectos de los fármacos , Caspasas/metabolismo , Humanos , Receptores de Muerte Celular/efectos de los fármacos
6.
Commun Integr Biol ; 5(2): 190-2, 2012 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-22808330

RESUMEN

Our recent findings indicate that cells exposed to transmembrane (m-CD95L) or metalloprotease-cleaved CD95L (cl-CD95L) undergo a localized Ca(2+)entry that not only inhibits the initial steps of the CD95-mediated apoptotic signal but also promotes cell motility. Based on recent findings published on the non-apoptotic signals induced by CD95, we discuss how m-CD95L and cl-CD95L diverging by their stoichiometry could both contribute to the immune response by first recruiting activated T lymphocytes in the inflamed area and later by eliminating infected and transformed cells.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA